Literature DB >> 3946807

Succinylcholine pharmacodynamics in peripartum patients.

B L Leighton, T G Cheek, J B Gross, J L Apfelbaum, B B Shantz, B B Gutsche, H Rosenberg.   

Abstract

Serum cholinesterase activity decreases 30% during pregnancy and remains depressed during the postpartum period. However, succinylcholine recovery is not prolonged in term-pregnant patients. This contrasts with results obtained in other patients with decreased serum cholinesterase activity. To better understand this paradox, the authors compared serum cholinesterase activity and recovery from succinylcholine, 1 mg/kg, in nonpregnant (with and without oral contraceptive use), in term-pregnant, and in postpartum patients. Serum cholinesterase activity was lower in both term-pregnant (3.66 +/- 0.39 U/ml, means +/- SE) and postpartum (2.84 +/- 0.35 U/ml) patients than in nonpregnant patients not taking oral contraceptives (5.01 +/- 0.33 U/ml, P less than 0.05). Cholinesterase activity in postpartum patients also was significantly lower than in nonpregnant patients taking oral contraceptives (4.81 +/- 0.63, P less than 0.05). In contrast, the time to 25% twitch-height recovery did not differ between term-pregnant (470 +/- 56 s) and nonpregnant patients taking (499 +/- 29 s) or not taking (501 +/- 21 s) oral contraceptives, but was significantly increased in postpartum patients (685 +/- 22 s, P less than 0.001). The similar duration of action of succinylcholine in term-pregnant patients (with decreased serum cholinesterase activities) and nonpregnant patients may be related to the increased volume of distribution of succinylcholine at term.

Entities:  

Keywords:  Age Factors; Anesthesia; Biology; Contraception; Contraceptive Agents, Female; Diseases; Drugs--administraction and dosage; Drugs--pharmacodynamics; Enzymatic Effects; Enzymes And Enzyme Inhibitors; Oral Contraceptives; Physiology; Population Characteristics; Pregnancy; Puerperium; Reproduction; Treatment

Mesh:

Substances:

Year:  1986        PMID: 3946807     DOI: 10.1097/00000542-198602000-00012

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  4 in total

Review 1.  Clinical pharmacokinetics of neuromuscular relaxants in pregnancy.

Authors:  J Guay; Y Grenier; F Varin
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

Review 2.  Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 3.  Pharmacokinetic optimisation of general anaesthesia in pregnancy.

Authors:  T Gin
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

4.  Plurietiologyc Possibilities and Difficulties of Seizures Management in Pregnancy.

Authors:  L T Rotaru; R M Popescu; C Boeriu
Journal:  Curr Health Sci J       Date:  2015-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.